Magnetic resonance imaging with gadoxetic acid for local tumour progression after radiofrequency ablation in patients with hepatocellular carcinoma
- 447 Downloads
To develop and validate a prediction model using magnetic resonance imaging (MRI) for local tumour progression (LTP) after radiofrequency ablation (RFA) in hepatocellular carcinoma (HCC) patients.
Two hundred and eleven patients who had received RFA as first-line treatment for HCC were retrospectively analyzed. They had undergone gadoxetic acid-enhanced MRI before treatment, and parameters including tumour size; margins; signal intensities on T1-, T2-, and diffusion-weighted images, and hepatobiliary phase images (HBPI); intratumoral fat or tumoral capsules; and peritumoural hypointensity in the HBPI were used to develop a prediction model for LTP after treatment. This model to discriminate low-risk from high-risk LTP groups was constructed based on Cox regression analysis.
Our analyses produced the following model: ‘risk score = 0.617 × tumour size + 0.965 × tumour margin + 0.867 × peritumoural hypointensity on HBPI’. This was able to predict which patients were at high risk for LTP after RFA (p < 0.001). Patients in the low-risk group had a significantly better 5-year LTP-free survival rate compared to the high-risk group (89.6 % vs. 65.1 %; hazard ratio, 3.60; p < 0.001).
A predictive model based on MRI before RFA could robustly identify HCC patients at high risk for LTP after treatment.
• Tumour size, margin, and peritumoural hypointensity on HBPI were risk factors for LTP.
• The risk score model can predict which patients are at high risk for LTP.
• This prediction model could be helpful for risk stratification of HCC patients.
KeywordsRadiofreqeuncy ablation Hepatocellular carcinoma Magnetic resonance imaging Prediction model Local tumour progression
local tumour progression
magnetic resonance imaging
hepatobiliary phase images
The scientific guarantor of this publication is Won Jae Lee. The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article. The authors state that this work has not received any funding. One of the authors (Sin-Ho Jung) has significant statistical expertise. Institutional Review Board approval was obtained. Written informed consent was waived by the Institutional Review Board. This is the first study using this kind of cohort. Methodology: retrospective, prognostic study / observational, performed at one institution.
- 3.Lee DH, Lee JM, Lee JY et al (2014) Non-hypervascular Hepatobiliary phase Hypointense Nodules on Gadoxetic Acid-enhanced MRI: Risk of HCC Recurrence after Radiofrequency Ablation. J HepatolGoogle Scholar
- 6.An C, Kim DW, Park YN, Chung YE, Rhee H, Kim MJ (2015) Single Hepatocellular Carcinoma: Preoperative MR Imaging to Predict Early Recurrence after Curative Resection. Radiology: 142394Google Scholar
- 15.Ariizumi S, Kitagawa K, Kotera Y et al (2011) A non-smooth tumor margin in the hepatobiliary phase of gadoxetic acid disodium (Gd-EOB-DTPA)-enhanced magnetic resonance imaging predicts microscopic portal vein invasion, intrahepatic metastasis, and early recurrence after hepatectomy in patients with hepatocellular carcinoma. J Hepatobiliary Pancreat Sci 18:575–585CrossRefPubMedGoogle Scholar
- 19.Min JH, Kim YK, Lim S, Jeong WK, Choi D, Lee WJ (2015) Prediction of microvascular invasion of hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging: Impact of intra-tumoral fat detected on chemical-shift images. Eur J RadiolGoogle Scholar
- 25.Merkle EM, Zech CJ, Bartolozzi C et al (2015) Consensus report from the 7th International Forum for Liver Magnetic Resonance Imaging. Eur RadiolGoogle Scholar
- 26.Haradome H, Grazioli L, Tsunoo M et al (2010) Can MR fluoroscopic triggering technique and slow rate injection provide appropriate arterial phase images with reducing artifacts on gadoxetic acid-DTPA (Gd-EOB-DTPA)-enhanced hepatic MR imaging? J Magn Reson Imaging 32:334–340CrossRefPubMedGoogle Scholar
- 29.Kang TW, Lim HK, Lee MW, Kim YS, Choi D, Rhim H (2013) First-line radiofrequency ablation with or without artificial ascites for hepatocellular carcinomas in a subcapsular location: local control rate and risk of peritoneal seeding at long-term follow-up. Clin Radiol 68:e641–e651CrossRefPubMedGoogle Scholar